Ashwin Ananthakrishnan News Today

The monoclonal antibody in development as maintenance therapy for people with moderately to severely active ulcerative colitis was more effective than placebo.

In part 2 of our 3-part series on the impact of clinical trials lacking diversity, we are spotlighting responses to our second question, which addresses how the previously established lack of diversity in clinical trials has had a direct effect on the development and application of new therapies or devices in real-world settings.

This article serves as a landing page for our 3-part series spotlighting how a lack of diversity in clinical trials has had a deleterious downstream effect on real-world care for people of color in the US, with perspective from experts across more than half a dozen specialties.

In the final part of our 3-part series, our panel of experts discuss what their fields and its leaders could do to make sure this lack of diversity in trials does not continue. These responses are highlighted in the following video and transcribed below.

What kids consume before the age of one could potentially determine their susceptibility to future illnesses.

Scientists do not know what causes inflammatory bowel disease, so preventive measures could be widely helpful.

A high quality diet at the age of 1 may curb the subsequent risk of inflammatory bowel disease, suggests a large long term study, published online in the journal Gut.

New research shows that toddlers who eat plenty of fish and vegetables, and precious few sugary drinks, are less likely to develop inflammatory bowel disease (IBD) by the time they are teenagers.

New research shows that toddlers who eat plenty of fish and vegetables, and precious few sugary drinks, are less likely to develop inflammatory bowel disease (IBD) by the time they are teenagers.

Ashwin Ananthakrishnan, MD, lead author of the new AGA guidelines, discussed using biomarkers over endoscopy in monitoring treatment response among specific types of CD.